The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
- PMID: 19538965
- PMCID: PMC2720067
- DOI: 10.1016/j.jim.2009.06.003
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Abstract
Immunoassays have made it possible to measure dozens of individual proteins and other analytes in human samples for help in establishing the diagnosis and prognosis of disease. In too many cases the results of those measurements are misleading and can lead to unnecessary treatment or missed opportunities for therapeutic interventions. These cases stem from problems inherent to immunoassays performed with human samples, which include a lack of concordance across platforms, autoantibodies, anti-reagent antibodies, and the high-dose hook effect. Tandem mass spectrometry may represent a detection method capable of alleviating many of the flaws inherent to immunoassays. We review our understanding of the problems associated with immunoassays on human specimens and describe methodologies using tandem mass spectrometry that could solve some of those problems. We also provide a critical discussion of the potential pitfalls of novel mass spectrometric approaches in the clinical laboratory.
Figures



Similar articles
-
Heterophile antibody interference affecting multiple Roche immunoassays: A case study.Clin Chim Acta. 2019 Oct;497:125-129. doi: 10.1016/j.cca.2019.07.010. Epub 2019 Jul 17. Clin Chim Acta. 2019. PMID: 31325446
-
Thyroglobulin antibodies--failing the test.J Clin Endocrinol Metab. 2011 May;96(5):1276-8. doi: 10.1210/jc.2011-0681. J Clin Endocrinol Metab. 2011. PMID: 21543436 No abstract available.
-
The investigation of interferences in immunoassay.Clin Biochem. 2017 Dec;50(18):1306-1311. doi: 10.1016/j.clinbiochem.2017.08.015. Epub 2017 Aug 26. Clin Biochem. 2017. PMID: 28847718 Review.
-
Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).Pain Physician. 2010 Jan-Feb;13(1):E1-E22. Pain Physician. 2010. PMID: 20119473 Clinical Trial.
-
Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays.Clin Chim Acta. 2002 Nov;325(1-2):1-15. doi: 10.1016/s0009-8981(02)00275-9. Clin Chim Acta. 2002. PMID: 12367762 Review.
Cited by
-
An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF.Alzheimers Dement (Amst). 2020 Jun 30;12(1):e12036. doi: 10.1002/dad2.12036. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32617385 Free PMC article.
-
Direct Detection of Conserved Viral Sequences and Other Nucleic Acid Motifs with Solid-State Nanopores.ACS Nano. 2021 May 25;15(5):8474-8483. doi: 10.1021/acsnano.0c10887. Epub 2021 Apr 29. ACS Nano. 2021. PMID: 33914524 Free PMC article.
-
Improving the Sensitivity of Protein Quantification by Immunoaffinity Liquid Chromatography─Triple Quadrupole Mass Spectrometry Using an Iterative Transition Summing Technique.Anal Chem. 2024 Sep 10;96(36):14326-14331. doi: 10.1021/acs.analchem.3c04598. Epub 2024 Aug 26. Anal Chem. 2024. PMID: 39186623 Free PMC article.
-
Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets.Front Immunol. 2021 Mar 24;12:650184. doi: 10.3389/fimmu.2021.650184. eCollection 2021. Front Immunol. 2021. PMID: 33868288 Free PMC article. Review.
-
Interference from anti-drug antibodies on the quantification of insulin: a comparison of an LC-MS/MS assay and immunoassays.Bioanalysis. 2024 Sep 12;16(17-18):1-11. doi: 10.1080/17576180.2024.2389637. Online ahead of print. Bioanalysis. 2024. PMID: 39262387 Free PMC article.
References
-
- Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics. 2006;5:573–588. - PubMed
-
- Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) J Proteome Res. 2004;3:235–244. - PubMed
-
- Annesley TM. Ion suppression in mass spectrometry. Clin Chem. 2003;49:1041–1044. - PubMed
-
- Berna MJ, Zhen Y, Watson DE, Hale JE, Ackermann BL. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem. 2007;79:4199–4205. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources